glp-1 drugs for weight loss pills The FDA has approved the first pill loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular The U.S. Food and Drug

doi: 10.2337/db20-89-LB 78 StensenSGasbjergLSKroghLLSkov-JeppesenKSparre-UlrichAHJensenMHet al

The medical use of GLP-1RAs started with T2DM treatment but now includes obesity management for patients whose BMI is 30 kg/m 2 or 27 kg/m 2 who also have weight-related health problems [9]

the agents that engage central targets, not the best-selling ones, are the ones worth testing, and brain-penetrant next-generation designs should take priority

The only GLP-1 analogues approved by the FDA are injections and semaglutide pills 1 , 2

Cardiovasc Diabetol 20:205

Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk The CARMELINA randomized clinical trial